TACE Combined with Portal Vein Tumor Thrombus 125I I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal ShuntsJOURNAL OF HEPATOCELLULAR CARCINOMAIF3.42024-09-010OAAI
Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective StudyCLINICAL AND TRANSLATIONAL GASTROENTEROLOGYIF32023-03-159OAAI
Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor ThrombusJOURNAL OF HEPATOCELLULAR CARCINOMAIF3.42023-02-013OAAI
Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulasFRONTIERS IN ONCOLOGYIF3.32022-10-055OAAI
Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective studyFRONTIERS IN ONCOLOGYIF3.32022-09-3019OAAI
Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinomaFRONTIERS IN ONCOLOGYIF3.32022-09-203OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向